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Synopsis 
 
There has been a 3-fold increase of Acanthamoeba keratitis amongst contact lens users in 
South-East England since 2010-11. Risk factors include Oxipol disinfection and lens 
contamination by water. Public health education could reduce the incidence.  
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Abstract 
 
Background/Aims 
Acanthamoeba keratitis (AK) is a chronic debilitating corneal infection principally affecting 
contact lens (CL) users.  Studies were designed to test claims that the UK incidence may have 
increased in 2012-14, and to evaluate potential causes.   
 
Methods 
Annualised incidence data was collected from January 1984-December 2016. Case control 
study subjects were recruited between 14-04-2011 and 05-06-2017. Reusable CL users with 
AK were recruited retrospectively and prospectively. Controls were reusable CL users, 
recruited prospectively, with any disorder other than AK. Multivariable analysis of 
questionnaire data measured independent risk factors for AK.  
 
Results 
The current outbreak of AK started in 2010-11 with an incidence 3-fold higher than in 2004-
9. Risk factors for AK were: Oxipol disinfection, CLs made of Group IV CL materials, poor 
CL hygiene, deficient hand hygiene, use of CLs whilst swimming or bathing, being white 
British, and for those in social classes 4-9.  
 
Conclusion 
AK is a largely preventable disease. The current outbreak is unlikely to be due to any one of 
the identified risk factors in isolation. Improving CL and hand hygiene, avoiding CLs 
contamination with water, and use of effective CL disinfection solutions, or daily disposable 
CLs, will reduce the incidence of AK. In the longer-term water avoidance publicity for CL 
users can be expected to reduce the incidence further. Ongoing surveillance of AK numbers 
by will identify changes in incidence earlier. Evaluation of Acanthamoeba contamination in 
end-user drinking water would contribute to our understanding of regional variations in the 
risk of exposure.    
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Introduction 
 
Acanthamoeba spp. are free-living cyst-forming protozoans, ubiquitous in air, soil, dust, and 
water, to which 50% - 100% of us develop antibodies. However, infections are uncommon, 
rarely involving the brain, but more often the cornea. Acanthamoeba exist as a vegetative 
trophozoite, usually feeding on other micro-organisms, whereas in the cornea they probably 
feed on keratocytes. In adverse environments, including the nutrient deficiency and noxious 
treatments that the organisms are exposed to in keratitis, trophozoites encyst. The cysts are 
extremely resilient and are the form of the organism responsible for persistent relapsing 
keratitis. (1)  
 
Despite its comparative rarity, and status as an orphan disease, AK is of concern because of 
its severe and prolonged morbidity in the young and economically active contact lens (CL) 
users who constitute 90% of affected patients in the UK. The most severely affected quartile 
require more than: 10 months treatment, 38 months follow up, 31 hospital visits, have less 
than 6/24 vision after resolution, and require corneal transplants.(2) Established independent 
risk factors for developing the disease have been exposure to water; in the context of CL use 
this risk has been related to exposure to domestic tap water both in the home(3, 4), and whilst 
swimming or bathing when wearing CLs.(4, 5) Others have been poor contact lens 
hygiene,(4-6) orthokeratology use of rigid CLs,(6) and lens disinfection solution failures 
which have resulted in previous outbreaks of AK both in the UK and USA.(7, 8) Following 
the last UK outbreak in 1991-5 a national incidence study reported a mean of 53 cases per 
annum of which 88% were in CL users(4); less than half the annual incidence at the peak of 
that outbreak.(7)  
 
Since then no increase in annual AK incidence has been noticed until concerns expressed in 
2012-14 (9, 10). As a result, we initiated the two studies reported here. Our results are likely 
to have relevance to the whole UK given that in 1997-9 Moorfields Eye Hospital 
(Moorfields) treated >75% of AK cases in the South East, and >35% of UK cases(4). The 
incidence study was to measure the annualized incidence at Moorfields. The case control 
study was designed to identify potential causes of AK, which we hypothesized might be 
largely due to ineffective CL solutions given the findings from previous outbreaks. (7, 11) 
The  
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Methods 
 
The studies were approved by the National Research Ethics Service Committee London-
Hampstead, REC Reference 13/LO/0032 and the Moorfields Eye Hospital Research 
Governance Committee. 
 
Incidence study of Acanthamoeba keratitis at Moorfields 1984-2016  
The data collection methodology for the numbers of cases of AK cases seen at Moorfields 
from January 1984-December 2016 has differed for different periods and are not directly 
comparable. The methodology is described in the Legend to Figure 1.(4, 7, 12, 13)  
 
Case control study  
Patients using CLs and attending Moorfields Accident and Emergency (A&E) Department 
completed a self-administered questionnaire based on those used in previous studies(7, 14), 
providing data on demographics, lens type, wear schedule, lens care and frequency of 
disposal, lens wear experience, frequency of practitioner aftercare, showering and bathing 
when wearing CLs, and smoking.  
 
Cases were reusable daily wear CL users diagnosed with Acanthamoeba keratitis having an 
initial attendance in the Moorfields A&E service. These included both self-referrals, 
secondary (general practitioner and optometric) and tertiary (other ophthalmology centres). 
These were identified between 14-04-2011 and 28-08-2014. Cases diagnosed before ethics 
approval was given on 18-2-2013 were recruited after diagnosis following which cases were 
recruited at the time of diagnosis. Inclusion criteria for Acanthamoeba keratitis cases were the 
same as those used for the Incidence study and are described in the Figure 1 Legend c, e.  
 
Controls were recruited prospectively. Like the cases, these were attending Moorfields A&E.     
Inclusion criteria were daily wear CL wearers using CL solutions as part of the hygiene 
routine for reusable CL’s having any disorder other than AK. Controls were identified in 2 
separate periods. This definition excluded users of true daily disposable and overnight (also 
known as continuous- or extended-) wear soft lenses for which no contact lens solutions were 
used. A first set of controls was collected between 17-02-2014 and 11-06-2015 and a second 
between 22-11-2016
 
and 05-06-2017. A diagnosis for each questionnaire respondent was 
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derived from the hospital notes. Disorders in the control CL user populations were classified 
into 2 subsets: those with CL related diseases and those with diseases thought to be unrelated 
to CL wear.  These conditions are listed in Supplementary Table 1. CL related diseases 
included all contact lens associated keratitis, other than AK, defined using criteria from 
previous studies.(14-16)  
Contact lens solutions were classified and analysed by the principal active ingredient using 
information derived from the packaging or manufacturers where possible or retailers when 
we could not establish the formulation from the first two sources. The classification is in 
Supplementary Table 2.  
Contact lenses were classified and analysed by their material using a simplification of the 
American National Standards Institute Terminology for Contact Lenses Reference Z80.20-
2016 and checked for each contact lens brand, or rebranded lens, against the UK Association 
of Contact Lens Manufacturers (ACLM) Annual Handbook for the years of the study. These 
data are summarised in Supplementary Table 3.   
Statistical methods 
The main analysis sample included all eligible controls collected during 2016-2017. A 
sample size of 60 cases and 180 controls was expected to provide 85% power (alpha 0.05) to 
detect a minimum odds ratio of 2.7% assuming 20% of the controls were exposed. Initial 
assessment of potential risk factors was carried out one at a time using logistic regression 
without adjustment for confounding and is described in Supplementary Table 4. Contact lens 
hygiene compliance is an important potential risk factor and the methodology for calculating 
the score used for this analysis is described in Supplementary Table 5.  Following this initial 
assessment multiple logistic regression models were constructed to obtain estimates of odds 
ratios (OR) adjusted for confounding effects. Odds ratios are reported in this study as 
estimates of relative risk. Variables selected initially for inclusion in the model building 
process were those having p-values of <0·2 from the unadjusted analysis together with 
variables thought a priori to be risk factors for AK: hygiene score, hand washing before lens 
handling, and the principal active ingredient of the disinfection solution. The distribution of 
cases and controls for these variables is shown in Table 1. In constructing each final 
multivariate (MV) model, one exposure variable was considered as the "exposure of main 
interest", and all others as "auxiliary factors" (potential confounders). The final MV model 
was thus optimized to estimate the adjusted OR for the "exposure of main interest”; covariate 
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adjustment is described in Supplementary Table 6.  The performance of logistic models - 
goodness-of-fit, and discriminatory ability - were assessed by calculating the Hosmer-
Lemeshow p-value, and area under the ROC curve respectively. The statistical package used 
was Stata v.14.2 (StataCorp, Texas, USA). 
 
Results   
Incidence study:  
Figure 1 shows the numbers of cases from 1985 to 31-12-2016. Annual numbers were 8 to10 
per annum (p.a.) from 2000-2003, after which there was an annual increase from between 15 
and 23 p.a. from 2004-2009, rising from 2010 to the current level of between 36-65 cases p.a. 
Estimates of CL wear prevalence are given for datapoints throughout this period.  
 
Case control study: 
There were 63 confirmed Acanth moeba keratitis cases in reusable CLs wearers, with no 
exclusions: 18 cases, diagnosed up to 22 months before 18-2-13 (when ethical approval was 
obtained), completed the study questionnaire retrospectively. The remaining 45 AK cases and 
all the controls completed the questionnaires at the time of diagnosis. Cases were compared 
independently with the two different control datasets; one additional case was excluded when 
the initial clinical diagnosis of AK was not confirmed on follow up. There were 56 eligible 
controls from the first control dataset from which CL using controls were excluded if they 
had CL related disease. Following the analysis of this dataset concern was expressed by an 
external advisor about a potential bias in the selection of these controls. As a result, we re-
opened the study to obtain the second, and fourfold larger control dataset of 213; exclusions 
were true daily disposable and overnight wear lens users, CL users with AK, 15 with missing 
CL solution or CL brand information (despite 3 contact attempts), 1 who left the Hospital 
before being seen for diagnosis, and 2 whose records could not be retrieved to confirm the 
outcome. The findings from the analysis of the first dataset were similar to those of the 
second. The second dataset was chosen for the analysis reported here as giving a more 
conservative estimate of some odds ratios. Differences between the two datasets made their 
combination inappropriate. The results of the assessment of putative risk factors for AK, 
carried out independently for each exposure without adjustment for confounding, are shown 
in Supplementary Table 4 for the 63 AK cases compared with the entire second control 
dataset of 213. This control dataset includes both subsets with (n=109) and without (n=104) 
CL related diseases. Both of these subsets of controls were included in the analysis as being 
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likely to give a conservative estimate of the relative risk of exposures for AK, given that 
these may be shared with the risks for some of the non-Acanthamoeba CL related keratitis 
conditions listed in Supplementary Table 1 which made up 64/109 (59%) of the diagnoses in 
this subset. The mean age in the whole sample was 33.9 (standard deviation 12.26). The 
median age was 30 (range 13-76), with 25th & 75th percentiles of 25 - 40 (inter-quartile 
range). The distribution was similar in cases and controls: median of 30 in both, and inter- 
quartile range 25-49 and 25-38 respectively. 33/63 (52%) of the cases, and 152/213 (71%) of 
the controls were female.  
 
 
Multivariate analysis for the control dataset of 213 controls  
The results of the analysis for reusable soft contact lenses, adjusted for confounding, are 
shown in Table 2. These show significantly increased risks of AK as a result of the following: 
• The use of Oxipol disinfection of 4.74 (CI 1·83-12.30, p 0.001) 
• Wearing Group IV (high water content, ionic hydrogel lenses) of 6·71 (CI 1·31-34·29 p 
0·022) 
• Poor CL hygiene practice of 3·34 (CI 1·52-7·38 p 0·003) 
• No, or uncertain, hand washing before lens handling of 3.65 (CI 1·52-8·77 p 0·004) 
• Wearing contact lenses in swimming pools or hot tubs of 3·49 (CI 1·51-8·04 p 0·003); 
• White British ethnicity of 4·82 (CI 1·61-14·46 p 0·005) 
• Occupation other than professional/director/senior official of 3·51 (CI 1·52-8·11 p 
0·003).  
Rigid gas permeable CL solutions were included in the lens disinfectant analysis and these 
solutions were associated with a higher risk of keratitis compared to the referent: this does 
not imply a higher risk for AK associated with rigid lens use per se.   
 
Discussion 
The current outbreak of Acanthamoeba keratitis in South East England and the UK 
The incidence study has confirmed a current UK outbreak in South East England starting in 
2010/11, resulting in a mean of 50.3 per annum (range 36-65) treated at Moorfields for the 
years 2011-2016 compared to the most accurate estimate of the numbers between outbreaks, 
of 18.5 pa at Moorfields from the prospective national audit carried out over 2 years in 1997-
9.(4) Given the limitations of the data collection methodology, particularly for the earlier 
years of the period 2000 to 2012, it is possible that the numbers of cases between 2000-2003 
Page 9 of 35
https://mc.manuscriptcentral.com/bjo
British Journal of Ophthalmology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
Acanthamoeba keratitis incidence and case control study  10
are underestimates. On the other hand, the apparent rise in cases in 2004, that was 
subsequently maintained until a further rise in 2010-2011, may relate to the outbreak in the 
USA due to the failure of the CL disinfectant AMO Complete Moisture Plus. The latter 
resulted in a 17-fold rise in cases in the USA but, following withdrawal of the solution, 
numbers have remained at similar levels for reasons that are unclear.(11) The industry data 
on CL user numbers in Figure 1 suggests that this current UK outbreak is independent of 
changes in the prevalence of CL wear.  
 
Risk factors for Acanthamoeba keratitis   
Between 80-90% of AK cases are potentially avoidable if effective disinfection systems are 
used, good CL hygiene practice followed, and exposure to water whilst using lenses is 
avoided.(4, 7) This current study confirms these previous risk factors and identifies new 
independent risk factors including deficient hand washing, race and occupation associated 
risks (which are probably surrog tes for safe CL lens use either from not receiving or 
following appropriate instruction). It has also confirmed our initial hypothesis that a contact 
lens solution may have been associated with the outbreak given that Oxipol based 
disinfection was also an independent risk factor (Odds ratio 4.74, CI 1·83-12·30, p 0·001). 
This risk is relatively low compared to that of the previous outbreaks of AK associated with 
CL solution failures: a 40-fold higher risk of AK for users of chlorine based disinfection 
systems in the UK(7) and 17-fold higher for users of AMO Complete Moisture Plus in the 
USA (8, 11). The occurrence of AK in an individual patient who has used Oxipol cannot be 
attributed only to the Oxipol disinfection because: AK develops in some patients who do not 
use Oxipol (not a necessary cause), and also many patients who use Oxipol do not develop 
AK (not a sufficient cause). The same applies to the other risk factors.  Since the time of the 
investigation Oxipol solution has been phased out by the manufacturer.  
 
Although most manufacturers test their solutions for activity against Acanthamoeba this is 
not mandatory, largely because there is no standard methodology for reproducible in vitro 
sensitivity testing; this has resulted in a wide range of results for different solutions 
depending on the strains tested, their age, and the storage and encystment methodology 
used.(17)  Independent testing, using rigorous methods, has shown that most multipurpose 
CL disinfection solutions in vitro may be ineffective against Acanthamoeba.(17) The issue of 
mandatory testing of contact lens disinfection solutions for activity against Acanthamoeba is 
being actively addressed in the USA(17) and an international testing standard is being 
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developed by the ISO TC 172/SC 7/WG 9 committee for Contact Lens Care Products. 
However, disinfection is not sterilisation, and current anti-microbial test standards demand 
log reductions not elimination. It is also important to understand that CL disinfection solution 
efficacy is not just related to the principal active ingredients, which is how the analysis in this 
study was performed,  but is the sum of a complex interaction of the disinfectants with the 
excipients; storage bottle; CL case; debris in the CL case; and the CL material. All of these 
may affect disinfection capability, a topic beyond the scope of this report but relevant to the 
fact that in this study we found polyhexanide based disinfection systems to be the most 
effective whereas polyhexanide was also the disinfectant in AMO Complete Moisture Plus; 
the principal cause of the last USA outbreak, but for which the disinfectant failure was 
attributed to other components.(8) 
 
Another novel independent risk factor identified in this study was the association with the use 
of Group IV contact lenses of 6·71 (CI 1·31-34·29 p 0·022). This had been identified as a 
borderline risk in our study of the previous UK outbreak.(7) Etafilcon A is one of many 
Group IV materials and is one of the most widely used in CL manufacture. However, in a 
previous study on the risks of CL associated keratitis Etafilcon A, when used as a daily 
disposable lens, was found to be less associated with (predominantly bacterial) keratitis than 
other lens types.(14)  We think that the potential reduction in the risk of the much more 
common problem of bacterial keratitis is likely to offset a possible increase in the risk of 
Acanthamoeba keratitis associated with Group IV CL materials. Therefore, we suggest that 
Group IV lens material users, rather than changing lens material, should optimize their lens 
hygiene, and avoid wearing CLs when exposed to water to minimize their risk of developing 
AK (which is already very small). Lens cleaning has the capacity to remove adherent 
Acanthamoeba.(18)  This paradoxical finding for Group IV lens materials, associated with 
potentially higher risks for AK but lower risks for bacterial keratitis, may be explained by 
differences in adhesion of Acanthamoeba and bacteria to different CL materials. Although 
not always consistent, and also strain dependent, bacteria generally adhere less to Etafilcon A 
than to hydrophobic lens surfaces (on Group III and many Group V silicone hydrogels).(19) 
Conversely, Acanthamoeba adherence has been shown to be greater to high water content and 
ionic hydrogel CLs (Group IV lenses) compared to low water content hydrogel CLs (Groups 
I and III)(20) although this may also be strain dependent.(18) On the other hand 
Acanthamoeba adhesion was shown to be higher to first and second generation Group V CLs 
than to Etafilcon A (Group IV) in another study which demonstrates some of the limitations 
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of the in vitro investigation of microorganism adherence to unworn CL surfaces given that 
this difference was reduced by the effects of lens wear deposits and bacterial biofilm (both of 
which enhance Acanthamoeba trophozoite adhesion).(21)   
 
Research findings that support the risks of exposure to contaminated water are numerous. 
Deficient hand washing (including drying after washing), and water activities whilst using 
contact lenses have been associated with AK in this and other studies. Showering in CLs was 
not a statistically significant independent risk factor in this study but, given known risks of 
exposure to contaminated water whilst wearing lenses in other contexts, this should be 
avoided. Contact lens case contamination by Acanthamoeba spp. has been found in 1-7% of 
asymptomatic CL users.(22) Most water that CL users are exposed to may be contaminated 
by Acanthamoeba; domestic tap water in Turkey(23), South Korea(24), Hong Kong(22) and 
the UK(3) as well as swimming pool, hot tub and lake water.(25) Furthermore, in a UK study 
genetically identical organisms were isolated in the domestic water supply of 6 patients 
having AK, where the disease is more common in hard water areas, (3) probably because 
lime-scale in taps provides an optimal environment for the organism.(4) A seasonal 
association with AK has been related to increased participation in swimming in the summer 
months(11). To establish whether there might have been a “London Olympic effect” since 
2012, resulting from increased participation in swimming by CL users we compared control 
data from a 2004/5 study(14) with this current data, but have shown no increase in swimming 
(Supplementary Table 7). 
 
Given the importance of contaminated domestic water supplies in these studies it follows that 
small changes in the disinfection of domestic water supplies, that might lead to an increase 
the exposure of the population to water contaminated by Acanthamoeba, could have a 
substantial effect on incidence of AK. The incidence of AK amongst CL users has 
historically been 5 to 15-fold higher in the UK than in other countries, probably as a result of 
contaminated domestic tank stored tap water.(3, 4) In the USA implementation of US 
Environmental Protection Agency (EPA) legislation in 2002, designed to reduce the chlorine 
generated, potentially carcinogenic, disinfection by-products, was temporally related to an 
outbreak of AK in the Chicago suburbs. This legislation had resulted in treatment plants 
introducing a number of measures to minimize disinfection by-products including a reduction 
in the amount of chlorine used and a switch to the use of chloramine, a less potent 
disinfectant than chlorine. Although these measures may have resulted in increased microbial 
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contamination of the water delivery pipes, providing a larger food source for Acanthamoeba 
and resulting in increased Acanthamoeba contamination at end user sites(26) this was not 
shown to have occurred in Chicago; a preliminary analysis of the USA 2004 national 
outbreak of AK could not find an association of AK cases with the use of chloraminated 
water supplies.(8) In the UK the 1998 European Council Directive 98/83/EC shared similar 
aims. Although the directive was not introduced formally into UK national law until January 
2010 (27), coinciding with the start of the current outbreak of AK, informal discussion with 
three of four major suppliers of water to the South East, and scrutiny of the Drinking Water 
Inspectorate website(27),  has not identified any changes in disinfection procedures in 2010-
11 which might have led to increased end user exposure to contamination by Acanthamoeba, 
above what are probably historically high levels due to the widespread use of domestic tank 
stored water in the UK.  
 
A potential weakness of this study is the difference in recruitment periods for cases and 
controls. We do not think that this is likely to have resulted in significant bias, due to changes 
in exposure to contact lens solutions, as there was overlap between the recruitment periods 
for the cases and that for the first control group for which findings were confirmed. 
Unfortunately changes in market share of contact lens disinfection solutions are proprietary to 
the manufacturers who have not felt able to make these available to us. On the other hand, 
one of the strengths of this study is our proven rationale for the choice of both cases and 
controls from patients attending Moorfields A&E service. This minimizes potential 
recruitment bias by recruiting both from a similar catchment area.  We have followed this 
practice in previous studies. (7, 14, 28) In the 2008 study we used both community derived 
CL controls chosen from the postal code areas in which the cases were living for comparison. 
However, the analysis was no different using these controls (both time consuming and costly 
to recruit) compared to the controls derived from the A&E Department, as in the current 
study. (14)  
 
This study has confirmed a persisting outbreak of AK in the south east of England, starting in 
2010-11. This probably reflects the situation elsewhere in the UK, at least for hard water 
areas. AK should be a largely preventable disease with over 90% of CL users developing AK 
having identifiable, avoidable risk factors.(4) We think it unlikely that the current outbreak 
results from any of these current risk factors in isolation. However, if the following measures 
are taken the risk of developing AK is likely to be very low:  improving CL and hand hygiene 
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when inserting lenses, avoiding the contamination of CLs with water including water 
activities whilst using CLs, avoiding the use of CL solutions by switching to daily disposable 
CL use or, for those continuing to wear re-usable lenses, maintenance of optimal lens care 
with effective solutions. Publicity for these measures, as in the 1991-95 UK outbreak(29), can 
be expected to rapidly reduce the incidence of AK. Water avoidance publicity for CL users 
(by water companies, water sports facilities, the CL industry, and Eye Care Professionals) can 
be expected to reduce the incidence in the longer term. The addition of  “no water” labelling 
on all CL packaging(30) should become mandatory. Ongoing surveillance of AK incidence 
by major UK ophthalmic units will identify future changes in incidence more rapidly than for 
this current outbreak. Surveillance of end-user domestic water contamination by the water 
companies is currently limited to measuring fecal bacterial contamination: the addition of 
Acanthamoeba to this panel can be expected to contribute to our understanding of local 
variations in the risk of exposure and make CL users aware of the importance of maintaining 
preventive measures.  
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Figure 1 Legend 
 
The total number of cases from 1984-2016 (33 years) totalled 709.  
The data collection methodology varied for different periods (labelled a-f). The colours 
identify the periods for which the same data collection methodology was used. The references 
retain the numbering they have in the text: 
(a) 1984-1996 data (blue bars) was published in a letter as a bar chart
12
 and was collected 
using the clinical and/or microbiological (culture or histology) criteria used in a 
previous study.
7
 
(b) 1997-1999 data (red bar) was available from a national survey
4
 for a 24 month period 
01-10-1997 to 30-09-1999 for which annual figures are not available: there were 37 
cases in this two year period. 
(c) From 2000 to April 2012 (green bars) cases were identified from our current 
microbiology laboratory electronic database, and an electronic letter search of our 
electronic patient database, both of which started in 2000. Criteria for inclusion were 
a positive Acanthamoeba culture, histopathological confirmation of trophozoites 
and/or cysts, culture-negative cases shown to have Acanthamoeba cysts on confocal 
microscopy, and those with a typical clinical course and response to treatment.
4
 
(d) From March 2012 to December 2013 (yellow bars) cases were identified 
prospectively as part of studies being carried out on AK using the criteria described 
for the (c) period.  
(e) From 01-01-2014 to 31-12-2016 (black bars) cases were identified by retrospective 
audit, using the same criteria as for (c) but with the addition of Acanthamoeba DNA 
identification by polymerase chain reaction (PCR) as an additional inclusion criterion. 
 
∗ https://www.statista.com/statistics/429790/wearers-of-contact-lenses-united-kingdom-
ireland/ [data from the Association of Contact Lens Manufacturers market report 
2014: technical summary] 
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Table 1  
Distribution of cases and controls for the variables that were potential risk factors for AK 
chosen for inclusion in the MV analyses.  
 
 
Variable Control Case Total 
Odds 
Ratio * p-value 
95% CI for 
Odds Ratio 
Lens disinfectant: classified by the principal active 
ingredient (PAI) see Note 1  
       
1: Polyhexanide (0·00005-0·0001) 90 11 101 Referent    
2: PQ +ALDOX/PQ + Alex** 26 9 35 2·83 0·038 1·06 7·57 
3: Hydrogen peroxide 3% 12 5 17 3·41 0·048 1·01 11·51 
4: Polyquad-1(0·0001%) + Polyaminopropyl 
    biguanide 
11 2 13 1·49 0·633 0·29 7·60 
5: Oxipol 55 29 84 4·31 < 0·001 2·00 9·33 
6: Rigid gas permeable lens solution 11 5 16 3·72 0·036 1·09 12·71 
Unknown 8 2 10     
Total 213 63 276     
CL Materials classification: simplified from the 
ANSI classification see Note 2 
       
Groups I + II + III 18 6 24 1·95 0·233 0·65 5·83 
Group IV 13 7 20 3·15 0·039 1·06 9·37 
Group VA 76 13 89 Referent    
Groups VB+VC 73 29 102 2·32 0·023 1·12 4·81 
Rigid gas permeable materials 11 5 16 2·66 0·113 0·79 8·91 
Unknown 22 3 25     
Total 213 63 276     
Hygiene Score: categories split between the top 
(worst) quartile of the sample and the rest see Note 3 
       
1: Good-Moderate (score 1·75-5·08) 174 30 204 Referent    
2: Poor (score 5·09-8·08) 39 33 72 4·91 < 0·001 2·68 8·98 
Total 213 63 276     
Hand washing before handling CLs        
1: No/unsure 27 21 48 3·71 < 0·001 1·90 7·22 
2: Yes 186 39 225 Referent    
Unknown 0 3 3     
Total 213 63 276     
Showering when wearing CLs        
1: No 141 25 166 Referent    
2: Yes 72 38 110 2·98 < 0·001 1·67 5·31 
Total 213 63 276     
Water activity using CL’s: categories combined        
1: None 114 20 134 Referent    
2: Ocean/Sea/River/Lake 42 9 51 1·22 0·649 0·52 2·89 
3: Public or Private Pool/Hot tub 57 31 88 3·10 0·001 1·63 5·91 
Unknown 0 3 3     
Total 213 63 276     
Ethnic group: for categories see Note 4        
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4: British (white) 141 54 195 Referent    
6: Other 72 6 78 0·22 0·001 0·09 0·53 
Unknown 0 3 3     
Total 213 63 276     
Occupation: for categories see Note 5        
1-3 Professional/Director/Manager/Associate 
professional & technical/senior officials  
163 36 199 Referent    
4-9 combined  50 22 72 1·99 0·029 1·07 3·70 
Unknown 0 5 5     
Total 213 63 276     
 
*   Odds ratios (OR) are not adjusted for confounding effects of other variables 
** PAI category 2: PQ +ALDOX/PQ + Alex = Polyquad-1 (0·001%) + ALDOX (0·0005%) or  
     Polyquad-1 (0·0003%) + Alexidine (0·00016%) - the latter for 4 controls and 1 case only. 
 
Notes 
1. Classification of CL solutions is given in Supplementary Table 2 
2. American National Standard Institute (ANSI) standard Z80.20-2016. American National Standard for 
Ophthalmics - Contact Lenses - Standard Terminology, Tolerances, Measurements and 
Physicochemical Properties. (Ophthalmic) 
3. Hygiene scores were calculated using the following rules: scores for different categories of each 
variable are listed in Table-H1 (Supplementary Table 3). Maximum & minimum scores for any 
category were 10 & 1 respectively. Some of the closely related original variable pairs were combined 
into a single analysis variable (see Table-H1). All the analysis variables were given equal importance 
(no weighting). For each patient, the scores were summed across all the variables, then divided by the 
number of observations (number of variables with score data), to arrive at a mean score for each 
patient. The objective was to maximise the difference in scores between those who completely deviated 
from "good hygiene practice" and those who were totally compliant with "good hygiene practice" 
(scores 10 & 1 respectively). Partial deviations were scored 5.  
4. Ethnic categories (UK Census categories): 1: Asian or Asian British (Bangladeshi, Indian, Pakistani) 2: 
Black or Black British (African, Caribbean, Other) 4: British (white) 6: Other 
5. Occupation: 1. Managers, directors and senior officials 2. Professional occupations 3. Associate 
professional and technical occupations 4. Administrative and secretarial occupations 5. Skilled trades 
occupations 6. Caring, leisure and other service occupations 7. Sales and customer service occupations 
8. Process, plant and machine operatives 9. Occupations requiring no specific training or skills & 
Student: categorized by parents’ occupation. 
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Table 2.  
Independent risk factors for AK from multiple logistic regression models using the 
Main Analysis Sample (213 Controls and 63 AK Cases). Odds ratios are adjusted for 
possible confounding. 
 
  
  Exposures 
  
Adjusted 
Odds Ratio 
(OR) *  
 
P value 
 
95% CI for OR 
  Lens disinfectant: classified by principal active ingredient (PAI) 
 see Note 1 
   
Polyhexanide (0·00005-0·0001%) (Referent)   
PQ +ALDOX/PQ + Alex** 2·32 0·184 0·67 - 8·04 
Hydrogen peroxide3% 1·77 0·534 0·29 - 10·83 
Polyquad-1(0·0001%) + Polyaminopropyl biguanide (0·00013%) 0·80 0·851 0·08 - 8·03 
Oxipol 4·74 0·001 1·83 - 12·30 
Rigid CL solutions 7·34 0·011 1·57 - 34·24 
CL Materials classification: simplified from the ANSI   
classification see Note 2 
   
Groups 1+2+3 2·39 0·313 0·44 - 12·98 
Group 4 6·71 0·022 1·31 - 34·29 
Group 5A (Referent)   
Groups 5B+5C 2·3 0·107 0·84 - 6·32 
Hygiene Score: categories split between the top (worst) quartile of 
the sample and the rest see Note 3 
   
Good-Moderate (1·75-5·08) (Referent)   
Poor (5·09-8·08) 3·34 0·003 1·52 - 7·38 
  Hand washing:    
Yes (Referent)   
No/unsure 3·65 0·004 1·52 - 8·77 
Shower wearing CLs:    
No (Referent)   
Yes  1·81 0·150 0·81 - 4·07 
Water Activities wearing CLs:     
None (Referent)   
In Ocean/Sea/River/Lake 1·45 0·519 0·47 - 4·45 
In public pool/private pool/hot tub 3·49 0·003 1·51 - 8·04 
Ethnic Group: for categories see Note 4    
Other  (Referent)   
White Caucasian     4·82 0·005 1·61 - 14·46 
Occupation: for categories see Note 5    
Class 1 + 2 + 3: Professional/Director/Senior Official (Referent)   
Classes 4-9:  3·51 0·003 1·52 - 8·11 
* In constructing each final MV model, one exposure variable was considered as the "exposure of main 
interest", and all others as "auxiliary factors" (potential confounders). The final MV model was thus 
optimized to estimate the adjusted odds ratio for the "exposure of main interest" (see Supplementary 
Table 6 Covariate adjustment) 
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** PAI category 2: PQ +ALDOX/PQ + Alex = Polyquad-1 (0·001%) + ALDOX (0·0005%) or 
     Polyquad-1 (0·0003%) + Alexidine (0·00016%) - the latter for 4 controls and 1 case only· 
 
Notes 
1. Classification of CL solutions is given in Supplementary Table 2 
2. American National Standard Institute (ANSI) standard Z80.20-2016 American National Standard for 
Ophthalmics - Contact Lenses - Standard Terminology, Tolerances, Measurements and 
Physicochemical Properties· (Ophthalmic) 
3. Hygiene scores were calculated using the following rules: scores for different categories of each 
variable are listed in (Supplementary Table 4). Maximum & minimum scores for any category were 10 
(poorest) & 1 respectively. Some of the closely related original variable pairs were combined into a 
single analysis variable (see Supplementary Table 4). All the analysis variables were given equal 
importance (no weighting). A mean score was calculated for each patient, and the patients were 
classified into 2 groups: using the top (worst) quartile of the mean score for the sample (5.09)  
4. Ethnic categories (UK Census categories): 1; Asian or Asian British (Bangladeshi, Indian, Pakistani) 2; 
Black or Black British (African, Caribbean, Other) 4; British (white) 6: Other 
5. Occupation: 1. Managers, directors and senior officials 2. Professional occupations 3. Associate 
professional and technical occupations 4. Administrative and secretarial occupations 5. Skilled trades 
occupations 6. Caring, leisure and other service occupations 7. Sales and customer service occupations 
8. Process, plant and machine operatives 9. Occupations requiring no specific training or skills, & 
Student: categorized by parents’ occupation 
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Supplementary Table 1  
Control contact lens users: diagnoses for the 213 Controls  
 
Diagnosis Frequency 
Diseases classified as unrelated to contact lens wear:  
listed by frequency 
Viral conjunctivitis 17 
Dry eyes 10 
Chalazion 5 
Posterior vitreous detachment  4 
Sub-tarsal foreign body 4 
Conjunctivitis 3 
Allergic conjunctivitis 3 
Blepharitis & dry eye 3 
Marginal keratitis & bilateral blepharitis 3 
Conjunctival abrasion (non-lens related) 2 
Ocular migraine 2 
Recurrent corneal erosion syndrome 2 
Chalazion & bilateral blepharitis 3 
Corneal foreign body 2 
Blepharitis 2 
Blepharitis & dry eyes 2 
Inflamed chalazion 1 
Corneal scar 1 
Acute anterior uveitis and right chalazion 1 
Acute anterior uveitis 1 
Meibomian gland dysfunction & dry eyes 1 
Corneal foreign body & conjunctival abrasion 1 
Lattice degeneration 1 
Sub-tarsal foreign body and corneal abrasion 1 
Ametropia 1 
Nothing found (given lid hygiene and/or 
lubricants) 
2 
Allergic reaction (lids) 1 
Blunt trauma 1 
Conjunctival retention cyst 1 
Eczematous lids 1 
Ocular hypertension 1 
Nothing found (possibly a systemic viral illness) 1 
Allergic reaction (lids) & dry eye 1 
In-growing eyelash 1 
Episcleritis 1 
Blepharitis and right acute hordeoleum 1 
Limbitis 1 
Dry eyes following viral conjunctivitis 1 
Chalazia 1 
Vitreous floaters 1 
Blepharo-conjunctvitis 1 
Marginal keratitis 1 
Optic neuritis 1 
Marginal keratitis & bilateral dry eyes 1 
Retrobulbar optic neuritis 1 
Optic disc drusen 1 
Preseptal cellulitis and bilateral blepharitis 1 
Preseptal cellulitis and chalazion 1 
 
 
 
 
 
Diseases classified as unrelated to contact lens 
wear:  
listed by frequency continued 
 
Diagnosis Frequency 
Marginal keratitis and blepharitis 1 
Scleritis 1 
Chemical keratitis 1 
Nothing found  1 
Total unrelated to Contact Lens wear 104 
 
Diseases classified as Contact Lens (CL) related: listed by 
frequency 
Corneal infiltrative event (CIE) 44 
CL overwear 23 
CL associated - microbial keratitis (MK) - 
moderate 
11 
CL associated - microbial keratitis - mild 8 
CL associated - uncertain whether a CIE or MK  1 
Corneal abrasion (1 in mild keratoconus patient) 8 
Toxic (chemical keratitis)  2 
CL related punctate corneal erosions (possibly fit 
related) 
1 
CL overwear & R conjunctival abrasion 1 
CL overwear & dry eyes 1 
CL overwear & corneal abrasion 1 
Conjunctival abrasion: CL related 1 
Scratched CL’s & CL related dry eyes 1 
CL related punctate epitheliopathy  1 
CL related corneal epitheliopathy 1 
Epithelial oedema: probably secondary to a tight 
CL 
1 
Epitheliopathy: probably CL solution related 1 
Retained CL with associated punctate corneal 
erosions 
1 
CL associated conjunctival hyperaemia 1 
Total CL-Related 109 
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1 
Supplem
entary T
able 2 
 C
ontact lens (C
L) solution inform
ation table (listed alphabetically by m
anufacturer (w
here know
n) and product nam
e)  
 
SO
FT
 C
L
 D
ISIN
FE
C
T
IO
N
 SO
L
U
T
IO
N
S U
nless stated data from
 A
C
LM
 handbooks, internet, solution packaging (B
oots and M
esm
ereyez) and online 
V
erified 
M
anufacturers  
nam
e 
R
ebranded  
nam
e 
A
ctive disinfectant(s) 
E
xcipients  (non-disinfectant ingredients)  
A
vailability 
at 01_ 2011  
Form
ulation 
source 
 
A
M
O
a O
xysept 1 
step 
N
ot applicable 
(N
A
) 
H
ydrogen peroxide 3%
  
N
eutralized w
ith enzym
e neutralizing tablet containing catalase, hydroxypropyl 
m
ethylcellulose, and cyanocobalam
in (vitam
in B
12) as color indicator, w
ith 
buffering and tableting agents. Solution also contains sodium
 stannate, sodium
 
nitrate, buffered w
ith phosphates and purified w
ater 
Y
es 
W
ebsite 
Y
 
A
M
O
 C
om
plete 
R
evitaLens 
N
A
 
Polyquaternium
-1 0.0003%
, 
A
lexidine dihydrochloride 
0.00016%
 
ED
TA
, Tetronic 904, boric acid/borate [1] 
Y
es 
K
ilvington, 
2010 
 
Y
 
A
lcon O
PTI-FR
EE 
EX
PR
ESS 
N
A
 
polyquaternium
-1 
(PO
LY
Q
U
A
D
®
) 0.001%
 and 
m
yristam
idopropyl dim
ethylam
ine 
(A
LD
O
X
®
) 0.0005%
  
Sodium
 citrate, sodium
 chloride, boric acid, sorbitol, am
inom
ethylpropanol, 
TETR
O
N
IC
®
 1304
d, w
ith edetate disodium
 0.05%
 
 
Y
es 
Package insert 
Y
 
A
lcon O
PTI-FR
EE 
PureM
oist 
N
A
 
polyquaternium
-1 
(PO
LY
Q
U
A
D
®
) 0.001%
 and 
m
yristam
idopropyl dim
ethylam
ine 
(A
LD
O
X
®
) 0.0006%
 
Sodium
 citrate, sodium
 chloride, boric acid, sorbitol, am
inom
ethylpropanol, 
disodium
 ED
TA
, tw
o w
etting agents (TETR
O
N
IC
®
 1304
d and H
ydraG
lyde®
 
M
oisture M
atrix [EO
B
O
-41®
 polyoxyethylenepolyoxybutylene])  
. 
N
o from
 June 
2011 
Package insert 
Y
 
A
lcon O
PTI-FR
EE 
R
epleniSH
 
N
A
 
polyquaternium
-1 
(PO
LY
Q
U
A
D
®
) 0.001%
 and  
m
yristam
idopropyl dim
ethylam
ine 
(A
LD
O
X
®
) 0.0005%
 
Sodium
 citrate, sodium
 chloride, sodium
 borate, propylene glycol, 
TEA
R
G
LY
D
E®
 proprietary dual action reconditioning system
 (TETR
O
N
IC
®
 
1304
 d, nonanoyl ethylenediam
inetriacetic acid)  
 
Y
es 
Package insert 
Y
 
A
SD
A
 A
ll in O
ne 
contact lens 
solution 
U
ncertain w
hether 
this is ow
n 
m
anufacture or 
rebranded 
Polyhexanide (PH
M
B
) 
(concentration unstated on 
packaging) 
Poloxam
er, H
PM
C
, sodium
 hyaluronate, sodium
 phosphate 
U
ncertain 
Phone interview
 
w
ith store staff 
Y
 
B
&
L
a B
iotrue 
N
A
 
Polyam
inopropyl biguanide 
(PA
PB
) 0.00013%
 &
 
polyquaternium
 0.0001%
. 
PA
PB
 and PH
M
B
 are 
interchangeable term
s c 
H
yaluronan, sulfobetaine, poloxam
ine, boric acid, sodium
 borate, edetate 
disodium
 &
 sodium
 chloride 
 
Y
es 
Package insert 
Y
 
B
&
L EasySept 
N
A
 
H
ydrogen peroxide 3%
 w
ith 
catalytic disc 
Phosphonic acid, phosphate buffers &
 sodium
 chloride 
 
Y
es 
Package insert 
Y
 
B
&
L R
enu M
PS 
for sensitive eyes 
N
A
 
Polyam
inopropyl biguanide 
(PA
PB
, D
Y
M
ED
®
) 0.00005%
 
B
oric acid, edetate disodium
, poloxam
ine, sodium
 borate &
 sodium
 chloride 
 
Y
es 
Package insert 
Y
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2 
B
&
L R
eN
u M
ultiplus 
B
&
L R
eN
u Fresh 
Polyam
inopropyl biguanide 
(PA
PB
, D
Y
M
ED
®
) 0.0001%
 
H
ydroxyalkylphosphonate (H
Y
D
R
A
N
A
TE®
), boric 
acid, edetate disodium
, poloxam
ine, sodium
 borate &
 
sodium
 chloride 
Y
es 
Package insert 
Y
 
B
oots C
L solution 
 
Polyam
inopropyl biguanide 
(PA
PB
)  0.0001%
 
PA
PB
 and PH
M
B
 are 
interchangeable term
s c  
H
ydroxyalkylphosphonate 0.03%
, poloxam
ine 1%
, 
boric acid, disodium
 edetate, sodium
 borate &
 sodium
 
chloride 
Sam
e form
ulation as 
B
&
L R
eN
U
 
M
ultiplus/Fresh  
Package insert 
Y
 
B
oots A
ll In O
ne 
 
Polyam
inopropyl biguanide 
(PA
PB
) 0.00005%
 
PA
PB
 and PH
M
B
 are 
interchangeable term
s c 
Poloxam
ine 1%
, boric acid, disodium
 edetate, sodium
 
borate &
 sodium
 chloride 
 
Sam
e form
ulation as 
B
&
L R
enu M
PS for 
sensitive eyes 
Package insert 
Y
 
C
iba V
ision  
A
O
Sept Plus 
N
A
 
H
ydrogen peroxide 3%
 w
ith 
catalytic disc 
Phosphonic acid, phosphate buffers, poloxam
er &
 
sodium
 chloride 
Y
es 
Package insert 
Y
 
C
iba V
ision Solocare A
qua
e 
M
enicon Solocare A
qua 
PH
M
B
 0.0001%
 
D
exapanthanol (provitam
in B
5), Trom
etham
ine, 
Sodium
 dihydrogen phosphate, Poloxam
er 407, 
Ethylenediam
inetetraacetic acid (ED
TA
), Sorbitol 
 
Y
es 
Product 
brochure 
Y
 
C
ooperV
ision  
O
ptions M
ulti 
N
A
 
PH
M
B
 0.0001%
 
B
orate buffers 
Y
es  
A
C
LM
 
H
andbook 
Y
 
C
ooperV
ision/Sauflon 
C
om
fortV
ue 
   
Procis Prem
ium
 A
ll in O
ne 
(O
ptic A
ctuell, G
erm
any).  
PH
M
B
 0.0001%
 
Poloxam
er, phosphate buffer, hydroxypropyl 
m
ethylcellulose 
 
U
ncertain 
A
C
LM
 
H
andbook 
Y
 
C
oopervision 
Sauflon Synergi 
easyvision all purpose 
(Specsavers, U
K
) A
N
D
  
Irisia Silicone H
ydrogel 
m
ultipurpose solution (France 
m
arketed by G
enerale 
d’O
ptique) 
O
xipol, O
xychlorite com
plex 
(sodium
 chlorite and hydrogen 
peroxide) 
Phosphate, poloxam
er, H
ydroxypropyl 
m
ethylcellulose (H
PM
C
), Polyvinylpyrrolidone (PV
P) 
[2] 
Y
es 
G
arcia-Porta, 
2015 
 
Y
 
C
oopervision 
Sauflon M
ulti 
easyvision peroxide 
(Specsavers, U
K
) 
 
H
ydrogen peroxide 3%
 w
ith 
platinum
 catalytic disc 
 
 Y
es 
A
C
LM
 
H
andbook 
Y
 
C
oopervision 
Sauflon A
ll in O
ne Light 
 
easyvision m
ultipurpose 
(Specsavers, U
K
) 
 
PH
M
B
 0.0001%
 
 
Phosphate, Poloxam
er, D
isodium
 edetate [3] 
Y
es 
B
eattie, 2003 
 
Y
 
    
 
easyvision ultrapurpose 
PA
PB
 0.0013 and 
Polyquaternium
 0.001%
 
H
ylauronan, Sulfobetaine (detergent that m
ay have 
antim
icrobial effects), boroc acid, sodium
 borate, 
ED
TA
, sodium
 chloride 
U
ncertain 
Phone interview
 
w
ith store staff 
Y
 
C
oopervision C
yC
lean 
 
PH
M
B
 0.0001%
                           Phosphate, Poloxam
er, H
PM
C
 (B
iopol), ED
TA
 
Y
es 
M
anufacturer  
N
 
M
enicon 
M
eniC
are Soft m
ultipurpose 
solution 
N
A
 
PH
M
B
 0.0001%
 
M
acrogolglycerol, hydroxystearate 60, ED
TA
, 
propylene glycol, tonicity agents (2) 
Y
es 
K
ilvington, 
2010 
Y
 
M
esm
erEyez m
ultipurpose 
soft lens solution 
U
nknow
n no response from
 
U
K
 distributor 
PH
M
B
 (concentration not on 
bottle or w
ebsite) N
o response 
ED
TA
, Poloxam
er, B
oric acid, Sodium
 borate, sodium
 
chloride, hydroxypropylm
ethylcellulose 
Y
es 
B
ottle label 
Y
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3 
to em
ail to com
pany on 
30_1_16  
M
orrison’s A
ll in O
ne contact 
lens solution 
N
ot clear w
hether this is ow
n 
brand or rebranded 
Polyhexanide (PH
M
B
) 
concentration not stated 
Sodium
 and potassium
 chloride, ED
TA
, poloxam
er, 
H
PM
C
, sodium
 hyaluronate, sodium
 phosphate 
U
ncertain 
From
 w
ebsite 
Y
 
O
ptical Express C
iel A
ll in 
O
ne contact lens solution 
O
w
n m
anufacture 
Polyhexanide (PH
M
B
) 
0,0001%
 
The active ingredient is the only one listed on the 
packaging  
U
ncertain 
Phone Interview
 
w
ith store staff  
 
Sainsbury’s all in one contact 
lens solution  
Proprietary to Sainsbury’s 
(East M
idlands 
Pharm
aceuticals) 
PH
M
B
 0.00015%
 
D
isodium
 Edetate, H
yprom
ellose, 
Poloxam
er, Sodium
 &
 Potassium
 C
hloride  
 
N
o from
 A
ugust 2012 
Product 
brochure 
Y
 
Tesco all in one contact lens 
solution  
Proprietary to Tesco’s (East 
M
idlands Pharm
aceuticals) 
PH
M
B
 0.0002%
 
D
isodium
 Edetate, Sodium
 H
yaluronate, 
H
yprom
ellose, Poloxam
er, Sodium
 &
 Potassium
 
C
hloride  
 
Y
es 
Product 
brochure 
Y
 
SO
FT
 C
L
 C
L
E
A
N
IN
G
 SO
L
U
T
IO
N
S 
EY
EY
E crystal cleaning 
solution now
 rebranded as 
O
té C
lean 40 
O
té Pharm
a Sol B
V
 
N
etherlands 5406 
PH
M
B
 0.002%
 as preservative  
N
on-ionogenic cleaning ingredients  
Y
es 
From
 bottle 
Y
 
R
IG
ID
 C
L
 D
ISIN
FE
C
T
IO
N
 SO
L
U
T
IO
N
S 
A
M
O
 Total C
are disinfecting, 
storing and w
etting solution 
N
A
 
PH
M
B
 0.0001%
 
 
Purified w
ater, trom
etham
ine, sodium
 chloride, 
hydroxypropylm
ethylcellulose, ED
TA
 and tyloxapol 
 
Y
es  
W
ebsite 
Y
 
B
&
L B
oston A
dvance 
N
A
 
chlorhexidine gluconate 
(0.003%
),  
PA
M
B
 (0.0005%
) 
  
C
ationic cellulose derivative polym
er, a cellulosic 
viscosifier, polyvinyl alcohol and a derivatized 
polyethylene glycol, edetate disodium
 (0.05%
). 
Y
es 
Package insert 
Y
 
B
&
L B
oston Sim
plus 
N
A
 
chlorhexidine gluconate 
(0.003%
), 
PA
M
B
 (0.0005%
)  
 
Poloxam
ine, hydroxyalkylphosphonate, boric acid, 
sodium
 borate, sodium
 chloride, hydroxypropylm
ethyl 
cellulose, G
lucam
 
Y
es 
Package insert 
Y
 
R
IG
ID
 L
E
N
S C
L
E
A
N
E
R
S 
B
&
L B
oston C
leaner 
N
A
 
PH
M
B
 0.0005%
 
C
hlorhexadine 0.003%
 
A
lkyl ether sulfate (9.8%
 w
/v), ethoxylated alkyl 
phenol, sodium
 chloride, silica suspension, sodium
 
phosphate dibasic and triquaternary cocoa base 
phospholipids  
Y
es 
B
ottle 
Y
 
EY
EY
E crystal cleaning 
solution now
 rebranded as 
O
té C
lean 40 
O
té Pharm
a Sol B
V
 
N
etherlands 5406 
PH
M
B
 0.002%
 as preservative  
N
on-ionogenic cleaning ingredients   
Y
es 
B
ottle 
N
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4 
aA
bbot M
edical O
ptics 
b B
ausch &
 Lom
b    
cPA
PB
 and PH
M
B
 are interchangeable term
s: the term
 quoted is the one given on the packaging.   
dTETR
O
N
IC
®
 is a registered tradem
ark of B
A
SF. 
e System
 contains antibacterial contact lens case 
 1 K
ilvington S, H
uang L, K
ao E, Pow
ell C
H
. D
evelopm
ent of a new
 contact lens m
ultipurpose solution: com
parative analysis of m
icrobiological, biological and clinical 
perform
ance. Journal of O
ptom
etry 2010; 3(3):134-142 
2. G
arcia-Porta N
, R
ico-del-V
iejo L, Ferreira-N
eves H
, Peixoto-de-M
atos SC
, Q
ueiros A
, G
onzalez-M
eijom
e JM
: Perform
ance of three m
ultipurpose disinfecting solutions 
w
ith a silicone hydrogel contact lens. B
ioM
ed research international 2015, 2015:216932. 
3. B
eattie TK
, Seal D
V
, Tom
linson A
, M
cFayden A
K
, G
rim
ason A
M
: A
m
oebicidal activity of m
ultipurpose contact lens solutions using a m
ost probable num
ber (M
PN
) 
enum
eration technique. J C
lin M
icrobiol 2003, 41:2992-3000. 
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Supplementary Table 3 
Contact lens types
CL Brand/Name = alternative name Water Oxygen Material Material
content permeability name Group
ACUVUE 2 colours (Johnson & Johnson) 58 21 Etafilcon A IV
ACUVUE 2/ BIFOCAL (Johnson & Johnson) 58 21 Etafilcon A IV
ACUVUE ADVANCE / ASTIGMATISM (Johnson & Johnson) 47 60 Galyficlon A VA
ACUVUE OASYS/ASTIGMATISM/ PRESBYOPIA (Johnson & Johnson) 38 107.4 Senofilcon A VA
AIR OPTIX AQUA/ ASTIGMATISM/ MULTIFOCAL (CIBA Vision) 33 110 Lotrafilcon B VC
AIR OPTIX Night and Day (CIBA Vision) 24 140 Lotrafilcon A VC
Avaira (CooperVision) 46 100 Enfilcon A VC
Biofinity /Toric/ Multifocal (CooperVision) 48 128 Comfilcon A VC
Biomedics 55 Evolution/ Toric (CooperVision) 55 19 ocufilcon D IV
Boots Night and Day (Boots) 24 140 Lotrafilcon A VC
Boots Monthly (Boots) = Premium-(Lotrafilcon B) 33 110 Lotrafilcon B VC
easyvision Monthly Classic/Aspheric/Toric/XR (Specsavers) = Coopervision Frequency 55 
55 19 Methafilcon A II
easyvision Irisian /Toric/Multifocal (Specsavers) = Air Optix for Astigmatism Monthly Toric (Ciba Vision) 33 110 lotrafilcon B VC
Easy Vision Irisian Sphere = Air Optix Aqua, monthly (Ciba Vision) 33 110 lotrafilcon B VC
easyvision Opteyes/Toric (Specsavers) = Biofinity Toric Monthly Toric (CooperVision) 48 128 Comfilcon A VC
easyvision Aquaeyes (Specsavers) = AirOptix Night and Day Aqua 24 140 Lotrafilcon A VC
EASYVISION UVICIA (silicone hydrogel) = Avaira 46 100 Enfilcon A VC
EASYVISION LACRIMA PLUS (silicon hydrogel) = clariti elite 56 60 somofilcon A VB
Expressions Colors (CooperVision) 55 19 Methafilcon A IV
Frequency 55 / Xcel Toric (CooperVision) 55 19 Methafilcon A IV
FreshLook Colorblends / Colors / Dimensions (CIBA Vision) 55 16 Phemfilcon A IV
Proclear/ Toric/ EP (CooperVision) 62 27 omafilcon B II
PureVision/ Toric/Multi-focal (Bausch & Lomb) 36 91 Balafilcon A III
PureVision  2 HD/ 2 HD for Astigmatism (Bausch & Lomb) 36 91 Balafilcon A VA
SofLens 38 (Bausch & Lomb) 38 6 Polymacon I
SofLens 59 (Bausch & Lomb) 59 17 Hilafilcon b II
SofLens Toric /Multifocal (Bausch & Lomb) 66 24 Alphafilcon a II
CRYSTAL (Ocuficon D 45%) 45 19.6 ocufilcon D III
GEO COLOUR (from Korea) = 'Circle' SCLs (large diameter) 42 9 polymacon I
CLARITI ELITE (silicon hydrogel) 56 60 somofilcon A VB
DESIO (Desiolens.com). Coloured, 62% polymacon, 38%WC) 38 9 poylmacon I
SEEQUENCE 55 38 9 polymacon I
Sauflon clariti 56 60 Somofilcon A VB
Ascend Premier = Biofinity 48 128 Comfilcon A VC
IWear XRT Supreme = Biofinity Toric ( available in LATAM) 48 128 Comfilcon A VC
Irisia care (monthly) 33 110 Uncertain VC
Lens material classification
Group I:     (low water (< 50%), non-ionic)   
Group II:    (high water (>/= 50%), nonionic)   
Group III:   (low water, (< 50%), ionic)   
Group IV:   (high water, (>/= 50%), ionic)  
Group V:    Materials with Dk > 40 Dk units (in mmHg) and greater than expected on the basis of water content
Group VA: Group 5 materials containing an ionic monomer or oligomer at pH 6-8   
Group VB: Group 5 non-ionic material containing > 50% water  
Group VC: Group 5 non-ionic material containing < 50% water 
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Supplementary Table 4  
Potential risk factors for AK, initially selected for inclusion in the model building process.  
Results from logistic models without adjustment for confounding. 
 
    Odds  95% CI for 
Variable Control Case Total Ratio1 p-value Odds Ratio 
 
Disinfectant classified by Principal Active 
Ingredient (PAI) 
       
1: PHMB (0.00005-0.0001) 90 11 101 Referent    
2: Polyquad-1(0.001%)+ALDOX (0.0005%) 2 26 9 35 2.83 0.038 1.06 7.57 
3: Peroxide3% 12 5 17 3.41 0.048 1.01 11.51 
4: Polyquad 1(0.0001%)+Polyaminopropyl biguanide 11 2 13 1.49 0.633 0.29 7.60 
5: Oxipol 55 29 84 4.31 < 0.001 2.00 9.33 
6: Rigid Gas permeable lens solutions  11 5 16 3.72 0.036 1.09 12.71 
Unknown 8 2 10     
Total 213 63 276     
        
        
        
Frequency of contact lens CL wear: days per week        
Up to 4 days 34 4 38 Referent    
> 4 days 179 57 236 2.71 0.070 0.92 7.95 
Unknown 0 2 2     
Total 213 63 276     
CL materials classification: 
based on FDA/ANSI standards listed in 
Supplementary Table 3 
       
Group 1 3 0 3 (empty)    
Group 2 13 6 19 2.70 0.086 0.87 8.37 
Group 3 2 0 2 (empty)    
Group 4 13 7 20 3.15 0.039 1.06 9.37 
Group 5A 76 13 89 Referent    
Group 5B 3 1 4 1.95 0.576 0.19 20.2 
Group 5C 70 28 98 2.34 0.023 1.12 4.87 
RGP 11 5 16 2.66 0.113 0.79 8.91 
Unknown 22 3 25     
Total 213 63 276     
CL grouping simplified:        
Groups I + II + III 18 6 24 1.95 0.233 0.65 5.83 
Group IV 13 7 20 3.15 0.039 1.06 9.37 
Group VA 76 13 89 Referent    
Group VB + VC 73 29 102 2.32 0.023 1.12 4.81 
Rigid gas permeable CL’s 11 5 16 2.66 0.113 0.79 8.91 
Unknown 22 3 25     
Total 213 63 276     
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    Odds  95% CI for 
Variable Control Case Total Ratio1 p-value Odds Ratio 
Hygiene Score (HS) Mean 4.30 5.09 4.47 ---- < 0.0014 ---- ---- 
Hygiene Score (HS) Categories3  
based on top (worst) quartile of the sample 
       
1: Good-Moderate (score 1.75-5.08) 174 30 204 Referent    
2: Poor (score 5.09-8.08) 39 33 72 4.91 < 0.001 2.68 8.98 
Totals 213 63 276     
Hand wash before handling CLs        
1: No/unsure 27 21 48 3.71 < 0.001 1.90 7.22 
2: Yes 186 39 225 Referent    
Unknown 0 3 3     
Total 213 63 276     
Shower wearing CLs        
1: No 141 25 166 Referent    
2: Yes 72 38 110 2.98 < 0.001 1.67 5.31 
Total 213 63 276     
Water activity wearing CLs        
1: None 114 20 134 Referent    
2:in Ocean/Sea/River/Lake 42 9 51 1.22 0.649 0.52 2.89 
3: in Public pool 46 23 69 2.85 0.003 1.43 5.68 
4: in Private pool 8 7 15 4.99 0.005 1.63 15.29 
5: in Hot tub 3 1 4 1.90 0.586 0.19 19.19 
Unknown 0 3 3     
Total 213 63 276     
Water activity: 3,4,5 combined        
1: Nowhere 114 20 134 Referent    
2: in Ocean/Sea/River/Lake 42 9 51 1.22 0.649 0.52 2.89 
3: Swimming Pools/Hot tub 57 31 88 3.10 0.001 1.63 5.91 
Unknown 0 3 3     
Ethnic group        
1: Asian 29 2 31 Referent    
2: British Other Black 16 1 17 0.91 0.938 0.08 10.79 
4: White Caucasian 141 54 195 5.55 0.022 1.28 24.08 
6: Other 27 3 30 1.61 0.616 0.25 10.39 
Unknown 0 3 3     
Total 213 63 276     
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    Odds  95% CI for 
Variable Control Case Total Ratio * p-value Odds Ratio 
Ethnic group: 1,2,6 combined        
4: White Caucasian 141 54 195 Referent    
6: Other 72 6 78 0.22 0.001 0.09 0.53 
Unknown 0 3 3     
Total 213 63 276     
Occupation5        
1-3 Professional/Director/Manager/Associate Professional 
Technical occupations  
163 36 199 Referent    
4 Administrative and secretarial occupations 16 6 22 1.70 0.302 0.62 4.64 
5 Skilled trades occupations 6 4 10 3.02 0.100 0.81 11.25 
6 Caring, leisure and other service occupations 8 4 12 2.26 0.201 0.65 7.93 
7 Sales and customer service occupations 13 7 20 2.44 0.077 0.91 6.54 
8 Process, plant and machine operatives 5 0 5     
9 Occupations requiring no training 2 1 3 2.26 0.509 0.20 25.65 
Unknown 0 5 5     
Occupation: categories 4-9 combined        
1-3 Professional/Director/Manager/Associate Professional 
Technical occupations 
163 36 199 Referent    
4-9 Categories 4 to 9 combined 50 22 72 1.99 0.029 1.07 3.70 
Unknown 0 5 5     
Total 213 63 276     
Education level        
1: up to A level 44 19 63 Referent    
4: Degree 96 28 124 0.68 0.260 0.34 1.34 
5: Higher Education 73 11 84 0.35 0.013 0.15 0.80 
Unknown 0 5 5     
Total 213 63 276     
	
1    Odds ratios (OR) are not adjusted for confounding effects of other variables 
2    PAI category 2 Includes Polyquad-1(0.001%) + ALDOX (0.0005%) AND (as used by 4 controls and 1 case) 
      Polyquad-1 (0.0003%) + Alexidine (0.00016%) 
3    Hygiene score categories based on worst (top) quartile of the mean hygiene scores in the sample. 
4    p-value of 0.0004 from non-parametric Mann-Whitney test 
5    Listed by categories 
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Supplementary Table 5  
Contact lens hygiene compliance assessment methodology  
	
Contact lens hygiene compliance was assessed by patient responses to 14 multiple choice questions. The 
responses to each question (or composite pair of questions) from each patient were assigned a score of 1 for full 
compliance, 5 for partial non-compliance, and 10 for complete non-compliance. An average score was then 
calculated for the patient. A single variable was created to hold all the mean scores. The questions were given 
equal importance (no weighting). Patients were then classified according to the quartiles of the mean score for 
the sample. A simpler binary classification was derived for MV analysis, based on the top (worst) quartile: 
"Good-Moderate" (mean score 1·75 - 5·08), and "Poor" (mean score (5·09 - 8·08). Hand washing before 
handling CLs and showering while wearing CLs were kept as separate variables and analysed as such. 
		
Category Hygiene question Variables Score Variable ID 
 Q23:  How often do you use disinfecting solution  1 
1 Always 1  
2 Uses extended wear disposable CLs, dispose on removal, no 
disinfectant (excluded from main analysis sample)* 
1  
3 Sometimes 10  
4 Never (excluded from main analysis sample)# 10  
 Q28:  How long had the bottle of solution been open  2 
1 1 to 30 days 1  
2 31 to 59 days 5  
3 60 or more days 10  
 Q29: Did you transfer your solution into another container   3 
 Q30: Did you use this transferred solution the last time you 
rinsed or stored the lenses 
 4 
1 Q29=No 1  
2 Q29=Yes, Q30=No 1  
3 Q29=yes, Q30=Unsure 5  
4 Q29=Yes, Q30=Yes 10  
 Q31: Did you rub your lenses the last time before you STORED 
them 
 5 
1 No 10  
2 Yes 1  
99 Unsure Blank  
 Q32: Did you rinse your lenses before you STORED them  6(a) 
 Q32n  If Yes, rinsed with what?  6(b) 
1 Q32=No 10  
2 Q32=Yes, Q32n=with Water 5  
3 Q32=Yes, Q32n=with disinfectant solution / Saline 1  
 Q33: Did you rinse your lenses the last time before you inserted 
them into your eyes 
 7(a) 
 Q33n: If Yes, with what?  7(b) 
1 Q33=No 10  
2 Q33=Yes, Q33n= disinfectant solution / Saline  1  
3 Q33=Yes, Q33n= Hot water  5  
4 Q33=Yes, Q33n= Warm water / Water  10  
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 Q34: Did you rub your lenses the last time before you inserted 
them into your eyes 
 8 
1 No 10  
2 Yes (all responses: "with disinfectant solution") 1  
 Q35:  Did you replace all the disinfecting solution in your case  9 
1 No, topped it up 10  
2 Yes  1  
99 Unsure Blank  
 Q36: After you took your contact lenses out, did you rinse your 
case  
 10 
 Q37: What did you rinse your case with  11 
1 No rinse 10  
2 Yes, with Saline 1  
3 Yes, with Water 5  
4 Yes, with disinfectant solution 1  
99 Unsure Blank  
 Q38: Did you empty your case and leave it to dry  12 
1 No 10  
2 Yes 1  
99 Unsure Blank  
 Q39: How old was your case when the symptoms started  13 
1 One to 90 days old 1  
2 More than 90 days 10  
 Q57: Where did you LAST carry out contact lens insertion and 
removal 
 14 
1 Bathroom 1  
2 Kitchen 5  
3 Bedroom 5  
4 Other 10  
99 Unsure Blank  
* The categories of lens are not reusable daily wear CL’s and irrelevant to the analysis 
# This category was for 7 controls using saline only 
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Supplementary Table 6  
Covariate adjustment 
 
Confounders (covariates) adjusted for in the final regression models constructed to estimate the odds ratios for a 
particular risk factor with optimal adjustment for confounding. 
 
 
Risk factor of 'main interest' 
 
 
Covariates adjusted for: 
 
Final 
Model # 
Lens Disinfectant (PAI) Hygiene Score; Hand washing; Shower wearing CLs; 
Water Activities wearing CLs; Ethnic Group; Occupation  
1 
CL Materials As for Model-1, but excluding Rigid CL solutions 2 
Hygiene Score As for Model-1, but excluding "Shower wearing CLs" 3 
Hand washing As for Model-3 3 
Shower wearing CLs As for Model-1 1 
Water Activities wearing CLs As for Model-3 3 
Ethnic Group As for Model-3 3 
Occupation As for Model-3 3 
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Supplementary Table 7  
Swimming whilst wearing contact lenses.  
 
Comparison of current dataset (collected 12-12-2013 to 05-06-2017 with dataset from a similar case control 
study of microbial keratitis (all causes) in contact lens users for data collected at Moorfields 03-12-2003 to 02-
12-2005 (Reference 14 in the Text: Dart JK, Radford CF, Minassian D, Verma S, Stapleton F. Risk factors for 
microbial keratitis with contemporary contact lenses: a case-control study. Ophthalmology 2008; 115(10): 1647-
54). 
 
 
Dataset and category Total number Users swimming in contact lenses 
Current study 12-12-2013 to 05-06-
2017 
 Number Percent 
Acanthamoeba keratitis cases 60 40 66.67 
Control dataset 22-11-2016 to 05-06-
2017 
213 99 46.48 
Cases and controls combined 273 139 50.92 
    
Dataset from 03-12-2003 to 02-12-2005 
study 
   
Microbial keratitis cases 366 224 61.20 
Population controls 637 326 51.18 
Hospital controls 1921 1103 57.42 
All cases and controls combined 2924 1653 56.53 
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